Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Schmidt

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Rheumatology|February 28, 2022
Introducing the international Myositis Society (iMyoS): a novel multiprofessional society to foster the care, education, and research on myositisJens Schmidt, Peter Korsten, Sabrina Zechel, et al.
Journal of Neuroimmunology|June 19, 2007
Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositisMohammad Salajegheh, Raghavan Raju, Jens Schmidt, et al.
Clinical and Experimental Rheumatology|February 5, 2025
Disease models of myositis: overview of cell culture and rodent systemsMichael Hauke, Mari Kamiya, Conrad Chris Weihl, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 20, 2019
Mechanic's hands in a patient with isolated anti-Ro52 antibodies: antisynthetase syndrome without antisynthetase antibodiesPeter Korsten, Jens Schmidt, Jörg Larsen, et al.
Brain : a Journal of Neurology|March 30, 2004
Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicityJens Schmidt, Goran Rakocevic, Raghavanpillai Raju, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Peter Korsten, Jens Schmidt, Jörg Larsen, et al.
Applied and Environmental Microbiology|November 22, 2011
Preliminary safety evaluation of a new Bacteroides xylanisolvens isolatePhilippe Ulsemer, Kawe Toutounian, Jens Schmidt, et al.
Rheumatology (Oxford, England)|August 5, 2019
Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositisPeter Korsten, Cornelia S Seitz, Carsten O Sahlmann, et al.
Nature Reviews. Rheumatology|April 21, 2018
Risk factors and disease mechanisms in myositisFrederick W Miller, Janine A Lamb, Jens Schmidt, et al.
Clinical and Experimental Rheumatology|February 12, 2026
Potential pitfalls in the differential diagnosis of myositis versus hereditary myopathiesStefanie Glaubitz, Rachel Zeng, Kanan Hasanov, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Rheumatology|February 28, 2022
Introducing the international Myositis Society (iMyoS): a novel multiprofessional society to foster the care, education, and research on myositisJens Schmidt, Peter Korsten, Sabrina Zechel, et al.
Journal of Neuroimmunology|June 19, 2007
Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositisMohammad Salajegheh, Raghavan Raju, Jens Schmidt, et al.
Clinical and Experimental Rheumatology|February 5, 2025
Disease models of myositis: overview of cell culture and rodent systemsMichael Hauke, Mari Kamiya, Conrad Chris Weihl, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 20, 2019
Mechanic's hands in a patient with isolated anti-Ro52 antibodies: antisynthetase syndrome without antisynthetase antibodiesPeter Korsten, Jens Schmidt, Jörg Larsen, et al.
Brain : a Journal of Neurology|March 30, 2004
Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicityJens Schmidt, Goran Rakocevic, Raghavanpillai Raju, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Peter Korsten, Jens Schmidt, Jörg Larsen, et al.
Applied and Environmental Microbiology|November 22, 2011
Preliminary safety evaluation of a new Bacteroides xylanisolvens isolatePhilippe Ulsemer, Kawe Toutounian, Jens Schmidt, et al.
Rheumatology (Oxford, England)|August 5, 2019
Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositisPeter Korsten, Cornelia S Seitz, Carsten O Sahlmann, et al.
Nature Reviews. Rheumatology|April 21, 2018
Risk factors and disease mechanisms in myositisFrederick W Miller, Janine A Lamb, Jens Schmidt, et al.
Clinical and Experimental Rheumatology|February 12, 2026
Potential pitfalls in the differential diagnosis of myositis versus hereditary myopathiesStefanie Glaubitz, Rachel Zeng, Kanan Hasanov, et al.
Pageof 12